Literature DB >> 15125351

[Mechanical ventilation in intensive care units: indications, modalities and complications. Results of a prospective multicenter survey in Tunisia].

Hedi Chelli1, Lamia Besbes, Jalila Ben Khelil, Hafedh Thabet, Bechir Bouhaja, Selma Ghedira, Salh Ben Lakhal, Afef Bchir, Mourad Gahbiche, Mounir Bouaziz, Souheil el Atrous, Mohamed Besbes, Mouldi Amamou, Mohamed Salah Ben Ammar, Abdelmajid Daoud, Slah Bouchoucha, Fekri Abroug.   

Abstract

The survey was performed during the month of March 1998 and concerned 9 ICUs located in teaching hospitals. To be included each ICU had to MV for more than 12 hours were included in the study and had a 28 day follow-up in the ICU or until hospital discharge. Collected parameters were indications of MV, modalities of MV and of weaning, complication and outcome at hospital discharge. Assist-control ventilation was the most used ventilation modality (69.8%). Weaning of MV was performed in 63% of the study patients and was based on a once-a-day attempt of spontaneous breathing through a T-piece (59.5%) and a combination of intermittent mandatory ventilation with pressure support (IMV-PS: 27%) or pressure support alone (11.2%). Mean length of hospital stay was 19.7 +/- 15.9 days of which 11.6 days were spent in the ICU. Fifty nine patients (54%) were alive at discharge form the ICU of whom 4 ultimately died during their hospital stay. MV practice as well as ICU facilities are not homogenous in Tunisia. Recommendations and guidelines should be built in order to standardize MV practice in Tunisia.

Entities:  

Mesh:

Year:  2004        PMID: 15125351

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

1.  Pattern of end-of-life decisions in two Tunisian intensive care units: the role of culture and intensivists' training.

Authors:  Islem Ouanes; Néji Stambouli; Fahmi Dachraoui; Lamia Ouanes-Besbes; Samir Toumi; Faouzi Ben Salem; Mourad Gahbiche; Fekri Abroug
Journal:  Intensive Care Med       Date:  2012-02-11       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.